2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF MEDICINAL CHEMISTRY J. Med. Chem. (此期刊被最新的JCR期刊SCIE收录) LetPub评分 8.4
72人评分
我要评分
声誉 9.0 影响力 7.8 速度 9.4 | |||||||||||||||||||||
期刊ISSN | 0022-2623 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1520-4804 | |||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 6.8 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:6.69 | |||||||||||||||||||||
2023-2024自引率 | 10.30%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 7.1 | |||||||||||||||||||||
JCI期刊引文指标 | 2.04 | |||||||||||||||||||||
h-index | 240 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://pubs.acs.org/journal/jmcmar | |||||||||||||||||||||
期刊投稿网址 | https://acs.manuscriptcentral.com/acs | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF MEDICINAL CHEMISTRY的语言要求,还能让JOURNAL OF MEDICINAL CHEMISTRY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF MEDICINAL CHEMISTRY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Transformative (TJ转换期刊是订阅式/混合期刊,但是正在积极转为完全开放获取期刊。查看ACS说明。) | |||||||||||||||||||||
通讯方式 | AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036 | |||||||||||||||||||||
出版商 | American Chemical Society | |||||||||||||||||||||
涉及的研究方向 | 医学-医药化学 | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Biweekly | |||||||||||||||||||||
出版年份 | 1959 | |||||||||||||||||||||
年文章数 | 922点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 13.77% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 98.81% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-2623%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2.1个月 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 较难 | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在JOURNAL OF MEDICINAL CHEMISTRY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
收稿范围 | 期刊官网数据: 期刊收录研究方向: 药理工具的新型生物活性化合物、诊断剂或标记配体的设计、合成和生物学评估 分子修饰以增进对构效关系(SAR)的认知。(没有创新性的化学或生物学方法或没有对SAR进行深入分析的常规工作通常将不予出版) 有关配体和靶标的结构生物学研究(X射线,NMR等),以探究生物活性化合物作用下的分子识别过程 大分子靶标的分子生物学研究(例如定点诱变)以增进对分子识别的理解 具有最新见解的化合物SAR计算研究,这些化合物当前具有普遍价值,或者可用于分析其他有用数据,从而进一步提高对药物化学的认知 新颖的计算化学方法,对于生物活性分子的鉴定、优化或标靶相互作用分析具有证明价值 分子结构对生物活性化合物的分布、药代动力学和代谢转化的影响。这可能包括新型药物前体的设计、合成和评估 可广泛应用于药物化学的新方法,且该方法已在相关分子上进行测试 | |||||||||||||||||||||
收录体裁 | 期刊官网数据: Articles Brief Articles Perspectives Drug Annotations Viewpoint Featured Articles | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small- cell Lung Cancer Author: Pei, Junping; Wang, Guan; Wang, Aoxue; Wu, Chengyong; Pan, Xiaoli; Shuai, Wen; Bu, Faqian; Zhu, Yumeng; Wang, Yuxi; Ouyang, Liang; Li, Weimin Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acs.jmedchem.3c00027 PubMed DOI |
2. | Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy Author: Zhu, Chenyu; Ze, Shuyin; Zhou, Ronghui; Yang, Xinyu; Wang, Haojie; Chai, Xiaolei; Fang, Meimiao; Liu, Mingyao; Wang, Yonghui; Lu, Weiqiang; Xie, Qiong Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 7, pp. 4734-4754. DOI: 10.1021/acs.jmedchem.2c018604734J PubMed DOI |
3. | Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway Author: Zhang, Xinqi; Han, Qianyu; Hou, Ruilin; Xu, Lijuan; Zhang, Wannian; Xing, Chengguo; Xue, Lei; Zhuang, Chunlin Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 7, pp. 5261-5278. DOI: 10.1021/acs.jmedchem.3c00197 PubMed DOI |
4. | Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives Author: Xie, Yuting; Yue, Lin; Shi, Yaojie; Su, Xingping; Gan, Cailing; Liu, Hongyao; Xue, Taixiong; Ye, Tinghong Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 7, pp. 4342-4360. DOI: 10.1021/acs.jmedchem.2c01753 PubMed DOI |
5. | Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling Author: Luo, Guangmei; Wang, Bingrui; Hou, Qiangqiang; Wu, Xiaoxing Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 7, pp. 4324-4341. DOI: 10.1021/acs.jmedchem.2c01729 PubMed DOI |
6. | Unsymmetrical Phosphodiesters as GPR84 Antagonists with High Blood Exposure for the Treatment of Lung Inflammation Author: Li, Shao-Xian; Wang, Si-Wei; Chen, Lin-Hai; Zhang, Qing; Lu, Dan; Chen, Jing; Fang, You-Chen; Gu, Min; Xie, Xin; Nan, Fa-Jun Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 8, pp. 5820-5838. DOI: 10.1021/acs.jmedchem.3c00053 PubMed DOI |
7. | Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1 Author: Gallego, Rebecca A.; Bernier, Louise; Chen, Hui; Cho-Schultz, Sujin; Chung, Loanne; Collins, Michael; Del Bel, Matthew; Elleraas, Jeff; Jones, Cinthia Costa; Cronin, Ciaran N.; Edwards, Martin; Fang, Xu; Fisher, Timothy; He, Mingying; Hoffman, Jacqui; Huo, Ruiduan; Jalaie, Mehran; Johnson, Eric; Johnson, Ted W.; Kania, Robert S.; Kraus, Manfred; Lafontaine, Jennifer; Le, Phuong; Liu, Tongnan; Maestre, Michael; Matthews, Jean; McTigue, Michele; Miller, Nichol; Mu, Qiming; Qin, Xulong; Ren, Shijian; Richardson, Paul; Rohner, Allison; Sach, Neal; Shao, Li; Smith, Graham; Su, Ruirui; Sun, Bin; Timofeevski, Sergei; Tran, Phuong; Wang, Shuiwang; Wang, Wei; Zhou, Ru; Zhu, Jinjiang; Nair, Sajiv K. Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 7, pp. 4888-4909. DOI: 10.1021/acs.jmedchem.2c02038 PubMed DOI |
8. | Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers Author: Qiu, Qianqian; Chi, Fanglian; Zhou, Daoguang; Xie, Zhancheng; Liu, Yunxiao; Wu, Hanyu; Yin, Ziyu; Shi, Wei; Qian, Hai Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acs.jmedchem.3c00036 PubMed DOI |
9. | Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects Author: Peng, Xiaopeng; Ren, Yichang; Pan, Wanyi; Liu, Jin; Chen, Jianjun Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 1, pp. 627-640. DOI: 10.1021/acs.jmedchem.2c01566 PubMed DOI |
10. | Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery Author: Song, Yihui; Wang, Shu; Yu, Bin Journal: JOURNAL OF MEDICINAL CHEMISTRY. 2023; Vol. 66, Issue 1, pp. 71-94. DOI: 10.1021/acs.jmedchem.2c01324 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室